Literature DB >> 12479973

Evidence that the anorexia induced by lipopolysaccharide is mediated by the 5-HT2C receptor.

Claudia von Meyenburg1, Wolfgang Langhans, Brian J Hrupka.   

Abstract

Rats consistently reduce their food intake following injections of bacterial lipopolysaccharides (LPS). Because inhibition of serotonergic (5-HT) activity by 8-OH-DPAT (5-HT(1A) activation) attenuates LPS-induced anorexia, we conducted a series of studies to examine whether other 5-HT-receptors are involved in the mediation of peripheral LPS-induced anorexia. In all experiments, rats were injected with LPS (100 microg/kg body weight [BW] ip) at lights out (hour 0). Antagonists were administered peripherally at hour 4, shortly after the onset of anorexia, which presumably follows the enhanced cytokine production after LPS. Food intake was then recorded during the subsequent 2 h or longer. 5-HT receptor antagonists cyanopindolol and SB 224289 (5-HT(1B)), ketanserin (5-HT(2A)), RS-102221 (5-HT(2C)), and metoclopramide (5-HT(3)) failed to attenuate LPS-induced anorexia. In contrast, both ritanserin (5-HT(2A/C)-receptor antagonist) (0.5 mg/kg BW) and SB 242084 (5-HT(2C)) (0.3 mg/kg BW) attenuated LPS-induced anorexia at doses that did not alter food intake in non-LPS-treated rats (all P<.01). Our results suggest that at least part of the anorexia following peripheral LPS administration is mediated through an enhanced 5-HT-ergic activity and the 5-HT(2C) receptor.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12479973     DOI: 10.1016/s0091-3057(02)01029-8

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  9 in total

1.  Dopamine-induced hypophagia is mediated by D1 and 5HT-2c receptors in chicken.

Authors:  Morteza Zendehdel; Keyvan Hasani; Vahab Babapour; Sepideh Seyedali Mortezaei; Yalda Khoshbakht; Shahin Hassanpour
Journal:  Vet Res Commun       Date:  2013-10-12       Impact factor: 2.459

2.  The role of central 5-HT(2C) and NMDA receptors on LPS-induced feeding behavior in chickens.

Authors:  Morteza Zendehdel; Majid Taati; Hosein Jonaidi; Elham Amini
Journal:  J Physiol Sci       Date:  2012-06-27       Impact factor: 2.781

3.  Intracerebroventricular injection of ghrelin produces hypophagia through central serotonergic mechanisms in chicken.

Authors:  Morteza Zendehdel; Kasra Mokhtarpouriani; Farshid Hamidi; Rohollah Montazeri
Journal:  Vet Res Commun       Date:  2012-10-12       Impact factor: 2.459

4.  The effect of serotonergic system on nociceptin/orphanin FQ induced food intake in chicken.

Authors:  Morteza Zendehdel; Kasra Mokhtarpouriani; Vahab Babapour; Ali Baghbanzadeh; Maryam Pourrahimi; Shahin Hassanpour
Journal:  J Physiol Sci       Date:  2013-04-25       Impact factor: 2.781

5.  Neurobiology of inflammation-associated anorexia.

Authors:  Laurent Gautron; Sophie Layé
Journal:  Front Neurosci       Date:  2010-01-08       Impact factor: 4.677

6.  Lipopolysacharide Rapidly and Completely Suppresses AgRP Neuron-Mediated Food Intake in Male Mice.

Authors:  Yang Liu; Ying Huang; Tiemin Liu; Hua Wu; Huxing Cui; Laurent Gautron
Journal:  Endocrinology       Date:  2016-04-25       Impact factor: 4.736

7.  A conscious mouse model of gastric ileus using clinically relevant endpoints.

Authors:  Matthew A Firpo; Michael D Rollins; Aniko Szabo; Justin D Gull; Jeffrey D Jackson; Yuanlin Shao; Robert E Glasgow; Sean J Mulvihill
Journal:  BMC Gastroenterol       Date:  2005-06-06       Impact factor: 3.067

8.  Dopamine D2/3 receptor antagonism reduces activity-based anorexia.

Authors:  S J Klenotich; E V Ho; M S McMurray; C H Server; S C Dulawa
Journal:  Transl Psychiatry       Date:  2015-08-04       Impact factor: 6.222

9.  Imaging evaluation of 5HT2C agonists, [(11)C]WAY-163909 and [(11)C]vabicaserin, formed by Pictet-Spengler cyclization.

Authors:  Ramesh Neelamegam; Tim Hellenbrand; Frederick A Schroeder; Changning Wang; Jacob M Hooker
Journal:  J Med Chem       Date:  2014-02-12       Impact factor: 7.446

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.